India's Tamil Nadu State Puts 24 Drugs, Devices On Substandard List
This article was originally published in PharmAsia News
India's southernmost state of Tamil Nadu has placed 24 drugs and medical devices on its blacklist of substandard drugs so far this year, including products ranging from over-the-counter drugs to needles and syringes.
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.